Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 46708-578

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 46708-578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Pack (Pramipexole 0375mg)

Pramipexole Dihydrochloride Extended-Release Tablets 0.375 mg in a 30-count package. The label shows the tablet strength, extended-release tablet form, and daily dose instructions. Manufactured by Alembic Pharmaceuticals Limited, the label includes storage instructions and a barcode with NDC 46708-574-30.*

FDA Label Image

30's Bottle Pack (Pramipexole 075mg)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 0.75 mg strength, oral tablet form. The label specifies once daily dosing and indicates the package contains 30 tablets. Manufactured by Alembic Pharmaceuticals Limited, it includes storage instructions and dispensing information. The NDC number 46708-575-30 and barcode are also visible.*

FDA Label Image

30's Bottle Pack (Pramipexole 15mg)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 1.5 mg, oral tablet dosage form. The label indicates it is a human prescription drug supplied by Alembic Pharmaceuticals Limited, containing 30 tablets per container. Storage instructions, dosage warnings, and a barcode are visible along with the NDC 46708-576-30.*

FDA Label Image

30's Bottle Pack (Pramipexole 225mg)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 2.25 mg strength, single tablet. The label indicates it is for oral use, once daily dosing, with 30 tablets in the container. Manufactured by Alembic Pharmaceuticals Limited, the label includes storage instructions, a barcode, NDC 46708-577-30, and prescription-only status.*

FDA Label Image

30's Bottle Pack (Pramipexole 375mg)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 3.75 mg strength. The oral extended-release tablets are supplied in a container of 30 count by Alembic Pharmaceuticals Limited. The label includes storage instructions, dosage administration notes, and a barcode. It states the tablets must be swallowed whole and carry a pharmacist dispensing advisory.*

FDA Label Image

30's Bottle Pack (Pramipexole 3mg)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 3 mg strength. The label includes storage instructions, dosage form as extended-release tablets, quantity of 30 tablets, manufacturer Alembic Pharmaceuticals Limited, and regulatory information such as NDC 46708-578-30. It specifies oral tablet use and indicates 'Rx only.'*

FDA Label Image

30's Bottle Pack (Pramipexole 45mg)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 4.5 mg strength, containing 30 tablets. The label includes storage instructions, dosage precautions, and manufacturer information for Alembic Pharmaceuticals Limited. It states the tablets must be swallowed whole and not chewed or crushed, and indicates the product is prescription only.*

FDA Label Image

Structure (Pramipexole Structure)

Chemical structure of Pramipexole Dihydrochloride illustrating its molecular framework with nitrogen, sulfur, and hydrogen atoms as part of the compound including the dihydrochloride and water components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.